IP Library Granted Patent US 8,187,860
Granted Patent B2
US 8,187,860 · App. 13/073,757 · Granted May 29, 2012

Recombinant microalgae cells producing novel oils

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,187,860
App. No.
13/073,757
Granted
May 29, 2012
Kind
B2
Abstract

Disclosed herein are obligate heterotrophic microalgae cells containing an exogenous gene. In some embodiments the gene is a sucrose utilization gene, and further disclosed are methods of manufacturing triglyceride oils using sugar cane or sugar beets as a feedstock in a heterotrophic fermentation. In other embodiments the feedstock is depolymerized cellulosic material. Also disclosed are cells that produce medium chain fatty acids at levels not produced in non-recombinant cells of the same species and genus.

Claims (19)

1. A cell of the genus Prototheca comprising an exogenous gene encoding a fatty acid desaturase, wherein the exogenous gene is integrated into the nuclear genome of the cell and is expressed thereby modifying the saturation of fatty acids in the cell.

2. The cell of claim 1 , wherein the fatty acid desaturase is selected from the group consisting of ω-6 fatty acid desaturase, ω-3 fatty acid desaturase, ω-6 oleate desaturase and stearoyl ACP desaturase.

3. The cell of claim 1 , wherein the coding sequence of the exogenous gene is in operable linkage with a promoter from a gene endogenous to a species of the genus Prototheca.

4. The cell of claim 1 , further comprising one or more additional exogenous genes, wherein the one or more additional exogenous genes are selected from the group consisting of a sucrose invertase gene, a fatty acyl-ACP thioesterase gene, a fatty acyl-CoA/aldehyde reductase gene, a fatty acyl-CoA reductase gene and a fatty aldehyde decarbonylase gene and integrated into a nuclear genome of the cell.

5. The cell of claim 4 wherein the cell is Prototheca moriformis, Prototheca krugani, Prototheca stagnora , or Prototheca zopfii.

6. The cell of claim 4 , wherein the one or more additional exogenous genes are selected from the group consisting of a sucrose invertase gene and a fatty acyl-ACP thioesterase gene.

7. The cell of claim 6 , wherein the additional exogenous gene is a fatty acyl-ACP thioesterase gene that encodes a fatty acyl-ACP thioesterase that has hydrolysis activity towards one or more fatty acyl-ACP substrates of chain length C8, C10, C12 or C14.

8. The cell of claim 4 , wherein the additional exogenous gene is a fatty acyl-ACP thioesterase gene that encodes a fatty acyl-ACP thioesterase that has hydrolysis activity towards one or more fatty acyl-ACP substrates of chain length C8, C10, C12 or C14.

9. The cell of claim 4 , wherein the cell is Prototheca moriformis.

10. The cell of claim 1 wherein the cell is Prototheca moriformis, Prototheca krugani, Prototheca stagnora , or Prototheca zopfii.

11. A method of making a triglyceride composition comprising cultivating the cell of claim 1 under heterotrophic conditions suitable for triglyceride production, thereby producing triglyceride in the cell.

12. The cell of claim 1 , wherein the cell is Prototheca moriformis.

13. A cell of the genus Prototheca comprising an exogenous gene that is integrated into a nuclear chromosome of the cell, wherein the integration of the exogenous gene ablates the expression of an endogenous fatty acid desaturase gene thereby modifying the saturation of fatty acids in the cell.

14. The cell of claim 13 , wherein the endogenous fatty acid desaturase is a stearoyl ACP desaturase.

15. The cell of claim 13 , wherein the exogenous gene encodes a fatty acid desaturase selected from the group consisting of ω-6 fatty acid desaturase, ω-3 fatty acid desaturase, ω-6 oleate desaturase and stearoyl ACP desaturase, and wherein the expressed exogenous gene modifies the saturation of fatty acids in the cell.

16. The cell of claim 13 , wherein the exogenous gene encodes for a selectable marker.

17. The cell of claim 16 , wherein the selectable marker is a sucrose invertase.

18. The cell of claim 13 further comprising one or more additional exogenous gene wherein the one or more additional exogenous gene is selected from the group consisting of a sucrose invertase gene, a fatty acyl-ACP thioesterase gene, a fatty acyl-CoA/aldehyde reductase gene, a fatty acyl-CoA reductase gene or a fatty aldehyde decarbonylase gene and is integrated into a nuclear genome of the cell.

19. The cell of claim 18 , wherein the one or more exogenous gene is a fatty acyl-ACP thioesterase gene that encodes a fatty acyl-ACP thioesterase that has hydrolysis activity towards one or more fatty acyl-ACP substrates of chain length C8, C10, C12 or C14.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2017
From: TERRAVIA HOLDINGS, INC.
To: CORBION BIOTECH, INC.
Reel/Frame 044424/0211 →
CHANGE OF NAME Recorded May 23, 2016
From: SOLAZYME, INC.
To: TERRAVIA HOLDINGS, INC.
Reel/Frame 038794/0867 →